Maravai LifeSciences Holdings, Inc. (MRVI)

MRVI Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	219.83	259.19	288.95	883	799.24	284.1
Revenue Growth (YoY)	-19.95%	-10.30%	-67.28%	10.48%	181.32%	98.48%
Cost of Revenue	152.71	150.88	148.74	168.96	140.56	79.65
Gross Profit	67.12	108.31	140.2	714.04	658.68	204.45
Selling, General & Admin	158.47	161.77	147.29	125.76	100.06	94.25
Research & Development	19.04	19.22	17.28	18.37	15.22	6.42
Operating Expenses	177.5	180.99	164.57	144.13	115.28	100.67
Operating Income	-110.39	-72.68	-24.37	569.92	543.4	103.78
Interest Expense	-38.49	-47.7	-45.89	-20.41	-30.26	-30.74
Interest & Investment Income	19.36	27.4	27.73	2.34	-	-
Other Non Operating Income (Expenses)	-3.96	-2.38	667.55	-4.46	6.38	0.13
EBT Excluding Unusual Items	-133.48	-95.36	625.02	547.38	519.52	73.17
Merger & Restructuring Charges	-0	1.21	-10.57	-3.5	-	-
Impairment of Goodwill	-209.04	-166.15	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	11.25	19
Other Unusual Items	-2.52	-1.18	3.29	7.59	-	-7.59
Pretax Income	-345.03	-261.48	617.74	551.47	530.77	81.7
Income Tax Expense	-3.82	-1.86	756.11	60.81	61.52	2.88
Earnings From Continuing Operations	-341.21	-259.62	-138.38	490.66	469.25	78.82
Minority Interest in Earnings	148.7	114.78	19.35	-270.46	-287.21	10.16
Net Income	-192.52	-144.85	-119.03	220.21	182.04	88.97
Preferred Dividends & Other Adjustments	-	-	-	-	-	12.08
Net Income to Common	-192.52	-144.85	-119.03	220.21	182.04	76.89
Net Income Growth	-	-	-	20.97%	104.60%	-
Shares Outstanding (Basic)	143	138	132	132	115	10
Shares Outstanding (Diluted)	143	138	132	255	258	29
Shares Change (YoY)	7.30%	4.54%	-48.33%	-0.96%	791.80%	-88.61%
EPS (Basic)	-1.35	-1.05	-0.90	1.67	1.59	7.43
EPS (Diluted)	-1.35	-1.05	-0.90	1.67	1.56	2.36
EPS Growth	-	-	-	6.97%	-33.73%	-
Free Cash Flow	-43.71	-22.19	60.67	518.89	353.72	126.78
Free Cash Flow Per Share	-0.31	-0.16	0.46	2.03	1.37	4.39
Gross Margin	30.53%	41.79%	48.52%	80.87%	82.41%	71.96%
Operating Margin	-50.21%	-28.04%	-8.43%	64.54%	67.99%	36.53%
Profit Margin	-87.57%	-55.88%	-41.19%	24.94%	22.78%	27.06%
Free Cash Flow Margin	-19.88%	-8.56%	21.00%	58.76%	44.26%	44.63%
EBITDA	-60.2	-24.3	15.89	601.75	568.15	129.62
EBITDA Margin	-27.39%	-9.38%	5.50%	68.15%	71.09%	45.62%
D&A For EBITDA	50.18	48.38	40.25	31.84	24.75	25.84
EBIT	-110.39	-72.68	-24.37	569.92	543.4	103.78
EBIT Margin	-50.21%	-28.04%	-8.43%	64.54%	67.99%	36.53%
Effective Tax Rate	-	-	122.40%	11.03%	11.59%	3.52%
Advertising Expenses	-	3.5	2.9	2.5	1.3	1.2

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q